Coldstream Capital Management’s United Therapeutics UTHR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.36M	Sell	2,295 -58	-2%	-$28.9K	0.02%	396
2025 Q4	$1.15M	Buy	2,353 +68	+3%	+$31.7K	0.01%	410
2025 Q3	$958K	Buy	2,285 +140	+7%	+$47.1K	0.01%	473
2025 Q2	$616K	Buy	2,145 +43	+2%	+$12.9K	0.01%	572
2025 Q1	$648K	Sell	2,102 -77	-4%	-$26.4K	0.01%	500
2024 Q4	$769K	Buy	2,179 +13	+0.6%	+$4.78K	0.02%	438
2024 Q3	$779K	Buy	2,166 +79	+4%	+$26.7K	0.02%	453
2024 Q2	$665K	Buy	2,087 +81	+4%	+$21.4K	0.02%	444
2024 Q1	$461K	Sell	2,006 -39	-2%	-$8.8K	0.01%	586
2023 Q4	$450K	Sell	2,045 -82	-4%	-$18.9K	0.01%	552
2023 Q3	$480K	Buy	2,127 +33	+2%	+$7.6K	0.02%	442
2023 Q2	$462K	Buy	2,094 +86	+4%	+$19K	0.01%	475
2023 Q1	$450K	Sell	2,008 -15	-0.7%	-$3.7K	0.02%	472
2022 Q4	$563K	Buy	+2,023	New	+$511K	0.02%	398
2022 Q2	$468K	Buy	1,989 +215	+12%	+$43.7K	0.02%	413
2022 Q1	$318K	Sell	1,774 -49	-3%	-$9.34K	0.01%	548
2021 Q4	$394K	Buy	+1,823	New	+$358K	0.01%	510